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ABSTRACT 
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During pregnancy in the mouse, extensive communication takes place between the 
conceptus (embryo/fetus and associated extraembryonic membranes) and uterus. Our 
focus centers on the uterine response to the conceptus. In ruminants, the conceptus 
produces interferon tau that induces interferon stimulated genes (ISGs) which likely 
regulate uterine receptivity, conceptus implantation, and conceptus growth and 
development.  Our hypothesis is that ISGs are similarly induced in uterus during 
pregnancy in the mouse.   If ISGs have a critical role in pregnancy establishment and 
maintenance in mammals, it is important to identify these ISGs in order to address 
fertility issues in human medicine. In this research, in situ hybridization analysis of uteri 
during gestation in the mouse was conducted to understand cell specific expression of 
selected ISGs during pregnancy.  Of the fifteen ISGs investigated, ten (Irf1, Irf2, Irf6, 
Irf7, Isg15, Oas2, Plscr1, Stat1, Rsad2, Tlr4) were found to be expressed in the uterus 
during pregnancy. 
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I       INTRODUCTION
1 
Understanding the mechanisms of reproduction is essential to the progress of 
modern society.  By elucidating the pathways of procreation, we can ensure the 
efficiency of our agriculture industry.  Considerable resources are required to maintain 
each bred cow, sow, or ewe, and, therefore, it is important that the young survive and 
can return a profit.  Currently, U.S. beef cattle herds average a pregnancy failure rate of 
nearly 30%, while increasing animal production by just 3% would result in 1 million 
more beef cows per year [1].  Additionally, understanding the molecular pathways of 
pregnancy will provide insight for development of new technologies in treating 
infertility, a hardship that will devastate 1 in 10 American couples in their reproductive 
years.  Conversely, this knowledge can lead to progress in contraceptive research, as the 
current birth control options are not free of side effects and contraindications and, 
therefore, prohibit our complacency in this area of research.  
 Therefore, this research aims to understand the cellular and molecular 
interactions of the conceptus, defined as the embryo/fetus and associated extraembryonic 
membranes, and the uterus during pregnancy.  The research carried out carries ethical 
limitations that prevent direct human experimentation.  The mouse was chosen as a 
model organism due to its short gestational cycle and its comparability to humans.   
 
A  Concepts of Pregnancy Establishment 
The mouse has an estrous cycle of 4-6 days in which fluctuating sexual 
receptivity physiologic behaviors can be observed.  This cycle is ultimately controlled by 
 
1This thesis follows the style and format of Reproductive Biology and Endocrinology. 
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the hypothalamic-pituitary-ovarian axis.  By convention, the first stage in the estrous 
cycle is called proestrus, and is that in which the follicles begin growing.  Proestrus is 
followed by estrus stage in which the female is sexually receptive to the male.  Pituitary 
luteinizing hormone (LH) induces ovulation in the mouse during estrus (spontaneous 
ovulation).  Following ovulation, LH acts on the remaining follicular tissue, inducing the 
development of the corpora lutea (CL).  Once developed, the CL function as endocrine 
glands secreting progesterone during diestrus.  In the event of successful mating, 
progesterone prepares the uterus for implantation and allows pregnancy establishment 
and maintenance.  If mating does not occur, the CL are quickly broken down.  This final 
stage is known as proestrus.  However, if mating does occur, the resulting cervical 
stimulation brings about twice daily secretions of prolactin from the pituitary.   Prolactin 
is trophic on the CL (“luteotrophic”) and prevents its breakdown (“luteolysis”).  The 
enduring CL continues to release progesterone for pregnancy [1-5].    
After mating, if fertilization is successful, the embryo undergoes its first cell 
division within 24 hours.  Cell division continues within the confines of the zona 
pellucida (ZP).  As a result, the cell number rapidly increases, while the total mass of the 
embryo does not significantly change.  During this cell division the embryo leaves the 
ampulla, the site of fertilization, and travels through the juxtaposed loops of oviduct, 
aided by peristaltic contractions, entering the uterus by gestational day 3 [5].  At this 
point in development, the morula are typically 16-32 cells and gross differentiation 
begins.  The first structural differentiation can be seen in which the uniformly clustered 
cells of the morula segregate forming the blastocyst which is characterized by a 
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peripheral layer of cells called the trophectoderm, and small clump of cells that 
aggregate on the deep surface of the trophectoderm.  This group of cells is termed the 
inner cell mass and becomes the embryo proper [1, 4-6].   
On day 3 the blastocyst hatches from the ZP [5, 7], which permits the 
trophectoderm to make necessary contact with the luminal epithelium (LE) during the 
stages of implantation.  In this process, the blastocyst secretes the protease strypsin, 
which digests a hole in the ZP.   Then the blastocyst completes its expulsion from the ZP 
via rhythmic contractions [8, 9].  The blastocyst will then continue to grow and make its 
way to its fated implantation site in the uterus. 
In all Eutherian mammals, implantation is dependent on a “two-way” molecular 
conversation between the conceptus.  Although this mechanism is highly complex, 
identification of certain phases in implantation can help simplify and elucidate the 
process.  The first recognized phase of implantation is attachment, which involves the 
apposition of the blastocyst to the uterine LE [10].  This activity is initiated by estrogen 
and then progesterone, which suppresses uterine epithelial cell proliferation and induces 
differentiation [7, 11].  The resultant rising levels of progesterone act on the uterus to 
promote the proliferation of stromal cells [7, 8, 11].  On day 4 of pregnancy, a small 
surge of ovarian estrogen initiates implantation of the blastocyst [7, 11, 12].  To this end, 
it has been shown that mice, ovariectomy on day four just prior to the estrogen surge 
delays implantation and induces dormancy of the blastocyst, because the ovarian 
originated estrogen surge is absent.   This state can be later reversed by injections of 
estrogen, and the blastocyst will implant [7, 11].  
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 Next, extensive stromal edema acts to progressively narrow the lumen of the 
uterus.  Progesterone furthers this process by inducing the uterine lumen to close tightly 
[8, 11], which ensures a juxtaposition of the conceptus trophectoderm and the uterine 
LE.   The trophectoderm and LE then attach together using cadherins, galectins, 
integrins, heparin sulfate, proteoglycans, and selectins, that trigger cell-to-cell signal 
transduction cascades [7, 8, 11].   
Following this resulting superficial attachment of the blastocyst to maternal 
tissue, the blastocyst trophectoderm invades the uterine tissue, completing implantation. 
This process is mediated by prostaglandins and histamines and results in an increase in 
vascular permeability in the localized endometrium.  Apoptosis of the luminal epithelial 
cells adjacent to the trophectoderm allows for the final invasion of the conceptus [7, 8].   
Concurrent with implantation, an additional process begins in which the 
endometrium undergoes significant changes in shape, organization, and metabolic 
requirements.  This process, called decidualization, produces a new uterine tissue known 
as the decidua.  Decidualization begins adjacent to the implantation site and commences 
with the appearance of trophoblast giant cells.  The goal of these cells is to modify the 
vasculature of the uterus, resulting in expansive, low resistance vessels that will allow 
the pooling of blood as part of the placenta [13, 14].  However, this mechanism must be 
restrained in preservation of the mother, because complete invasion of uterine arteries 
will result in severe hemorrhage, hypovolemic shock, and death.  Decidualization is this 
protective restraint.  The decidua possesses dense cellular matrix that impedes 
trophoblast invasion and instead enables trophoblast attachment [14].  This reaction that 
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began juxtaposed to the conceptus progressively continues throughout the endometrium 
over the next several days [13].  The effect is the replacement of endometrial stroma 
with the decidua in a progression that radiates away from the implantation site.  
 
B Interferon-Stimulated Genes 
Interferons (IFNs) are molecules primarily responsible for the defense against 
viral infection.  Two classes of interferons have been identified:  Type I IFNs and Type 
II IFNs.  The presence of viral component particles in a cell, especially double stranded 
RNA, cause the cells to produce Type I IFNs, which then induce ISGs in neighboring 
cells [15-18].  ISGs defend these neighboring cells from viral infection.  In fact, null 
mice for various components of the IFN system develop severe disease when infected 
with certain viruses that are typically symptom-less in wild time mice [16, 18]. ISGs 
have a vast range of functions that aim to prevent viral infection, including inhibition of 
further protein synthesis, inactivating energy stores, signal transduction, etc. [19].  These 
functions collectively act to fight against infection perpetuation in the host. 
In the 1980s, a new function was added to the repertoire of Type I IFNs with the 
discovery of interferon tau (IFNT).  During the establishment of pregnancy in ruminants, 
IFNT is produced by the conceptus and acts to prolong the lifespan of the CL.  In 
ruminants, the CL is normally triggered to break down by PGF2α [10, 15, 20-22]. This 
effectively inhibits luteolysis, the destruction of CL.  Thus, CL can continue to secrete 
progesterone, which is required for establishment and maintenance of pregnancy.  
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IFNT, like other Type I IFNs, has the ability to induce ISG expression.  As such, 
it has been previously shown that many ISGs are expressed in the ruminant uterus during 
early pregnancy [23].  It is believed that some of these ISGs mediate maternal-conceptus 
communication and uterine receptivity.  IFNT is present only in ruminants.  Although 
mice and humans, therefore, do not have the IFNT gene, ISGs are still expressed in the 
uterus and decidua during pregnancy.  Most notably ISG15 expression is present in the 
uterine tissues of ruminants, primates, and rodents (specifically sheep, humans, and 
mice, respectively) [10, 24, 25].   
Many ISGs are induced by Type I IFNs via the Janus tyrosine kinase and signal 
transducers and activators of transcription (JAK-STAT) pathway.   In this pathway, 
circulating Type I IFNs bind to a transmembrane receptor on the external surface of the 
membrane, which is composed of two subunits IFNAR1 and IFNAR2.  When this 
receptor is triggered, it activates two kinases, Tyk1 and JAK1 on the cytoplasmic side of 
the membrane, resulting in their phosphyorylation.  Once activated, Tyk1 acts back on 
the IFNAR1 subunit, which allows for the sequential recruitment and phosphorylation of 
STAT2 and STAT1.  STAT2 and STAT1 form a complex, which then travels to the 
nucleus where it binds with other transcription factors, including IRF9.  This new 
complex binds to a specific IFN-stimulated response element (ISRE) on the promoter 
region of ISGs to regulate their transcription [26].  
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II       ISGs 
The aim of this research is to determine if expression of various ISGs are 
expressed in the pregnant mouse uterus.  Therefore, several ISGs have been selected for 
evaluation. 
 
A  Characteristics of Selected Genes 
Interferon stimulated gene 15 (Isg15) 
Functionally, ISG15 conjugates intracellular proteins, signaling a pathway that is 
thought to be similar to ubiquitin [27].  Isg15 was one of the first ISGs discovered in the 
mouse [24].  Isg15 null mice typically show no reproductive, developmental, or viability 
effects [28].   However, UBP43 is a protease that removes ISG15 tags from ISGylated 
proteins, and Ubp43 null mice demonstrate heightened antiviral activity [27].  
Additionally, ISG15 is expressed in the endometrium during implantation in humans 
[24], pigs[29], cows[30-32], and mice[10, 24].   
 
 0BInterferon regulatory factor 1 and 2 (Irf1 & Irf2) 
Irf1 is induced by Type I and II IFNs.  IRF1 actions are functionally diverse, 
including apoptosis regulation, antiproliferative effects, natural killer cell  (NK) 
development, signal transduction mediation, and transcription regulation of Type I IFNs  
[33, 34]. 
IRF1 and IRF2 actions are antagonistic.  IRF2 suppresses the IRF1 response 
through competitive inhibition.  Murine knockouts for Irf1 show decreased immune 
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response when subjected to LCMV infection, a pathologically well-documented 
laboratory virus, while mice lacking the Irf2 gene demonstrate a hypersensitivity to 
antigens and over production of ISGs [35, 36].  Therefore, it is believed that IRF2 acts to 
safeguard the body against the harmful effects of an overly vigilant immune system [35].  
Interestingly, it has been recently shown that in somatic cells antiestrogens induce IRF1, 
while estrogens suppress it. Additionally, IRF1 increases cell sensitivity to anti-
estrogens [37].  
 
 1BInterferon regulatory factory 6 (Irf6) 
Irf6 is a transactivator and a member of the class of interferon regulatory factors.  
IRF6 is associated development of craniofacial, epidermal, and limb connective tissue 
[38].  In humans, deficiencies in Irf6 is associated with Popliteal Pterygium Syndrome, 
which is symptomatically characterized by cleft palate, webbing of limb joints, as well 
as other less conserved manifestations.  In mice, deficiencies in Irf6 are perinatal lethal 
[38, 39].   IRF6 plays a role in embryo development, though the function and regulatory 
mechanisms are not well understood.   Additionally, IRF6 is known to be absent in some 
carcinomas [40].  This finding, in conjunction with the pathology of Popliteal Ptergium 
Syndrome, lends speculation that IRF6 induces apoptotic activity essential for tissue 
remodeling. 
 
 
 
9 
 
 
 
 
Interferon regulatory factor (Irf7) 
Irf7 is one of the genes that is directly responsible for the induction of Type I 
IFNs.  During viral infection, the Irf7 gene is phosphorylated, which allows it to interact 
with transcriptional coactivators, inducing IFNA and IFNB production [41].   IRF7 is 
responsible for transitioning a virus to from primary infection to latency [42].   Also, Irf7 
null mice have marked viral infection susceptibility, and IRF7 is necessarily required for 
efficient antiviral activity [42, 43].  In fact, recent studies have turned some of the 
spotlight of Type I IFN response initiation away from IRF1 and toward IRF7 [42].  A 
few researchers have even gone so far as to name Irf7 as the „master regulator‟ of the 
antiviral response [43, 44].     
 
Phospholipid scramblase 1 (Plscr1) 
A common feature of healthy cells is asymmetry across the cell‟s plasma 
membrane.   In other words, the phospholipid layer has a directionality in which certain 
classes of phospholipids reside on each side of the membrane.  However, this asymmetry 
is obliterated as a step in signaling apoptosis [45, 46].  This response is largely mediated 
by the PLSCR class of molecules.  PLSCR1 effectively „scrambles‟ the phospholipids in 
a random, two-directional manner across the membrane.  Additionally, PLSCR1 can 
bind to genomic DNA and induce cell
 
proliferation and differentiation.  These functions 
are especially induced in the presence of IFN; in fact, although Plscr1 null mice have no 
apparent deficiencies, PLSCR1 is strongly induced by IFNs [47, 48]. 
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Signal transducer and activator of transcription 1 (Stat1) 
STAT proteins play a vital role in cell proliferation, differentiation, and signal 
transduction by controlling related transcription factors [49, 50].   IFNA has a 
considerable influence on the production and activation of STAT1 [49, 50],  and STAT1 
activates transcription of ISGs [26].  Additionally, Stat1 null mice show signaling 
defects when mounting an interferon response [51-53]. 
 
N-myc (and STAT) interactor (Nmi) 
The Stat and Myc gene classes are known to play important roles in cell 
differentiation and proliferation, and whole organism development.    Nmi has a 
significant influence on the activity of the Myc and Stat genes [54], and therefore, acts to 
regulate other transcriptional factors involved in paracrine signaling of other cytokines 
and hormones.  
 
Radical S-adenosyl methionine domain containing 2 (Rsad2)  
Rsad2 is a known antiviral protein that is induced by Type I interferons.  
Additionally, Rsad2 is expressed in the presence of conceptus-secreted IFNT during 
pregnancy in sheep and cows, and it is thought to have a vital role in the maintenance of 
pregnancy [23]. 
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2'-5' oligoadenylate synthetase 2 (Oas2) 
Oas2 has an important role in viral RNA degradation, namely OAS2 cleaves 
viral mRNA from rRNA [55].   Other cellular roles include apoptosis induction and 
growth regulation [56].  Additionally, Oas2 is a well-established pregnancy induced ISG 
in sheep [57]. 
 
Toll-like receptor4 (Tlr4) 
TLR4 activity induces Type I IFNs [58].  However, unlike the molecules discuss 
thus far, TLR4 is specialized not for the antiviral response, but as an antibacterial 
defense.  TLR4 recognizes lipopolysaccharide subunits, the differentiating component of 
gram negative bacterial walls and then initiates an immune response [59].  Interestingly, 
the conceptus shows restrained immunological activity while in the uterus, however, it 
has been recently shown that trophoblast cells not only have the ability to express Tlr4, 
but also that signaling from TLR4 could initiate the immunological interactions of 
implantation [60, 61]. 
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III   MATERIALS AND METHODS 
All experiments and surgical procedures were approved by the Institutional 
 
Animal Care Committee of Texas A&M University.  Mice were kept under light 
controlled conditions with free access to food and water.  Females were placed with 
fertile males, and the morning that a vaginal plug was observed was considered 
gestational day 1.  Pregnant mice were maintained
 
according to normal husbandry 
practices.  Mice were sacrificed by cervical dislocation on differing gestational days. 
The entire reproductive tract
 
(uterus and ovary) was excised, and the uterus was trimmed 
free
 
of the broad ligament, oviduct, and cervix. Sections from the
 
middle of each uterine 
horn (approx. 0.5 cm) were fixed in 4% (w/v) paraformaldehyde
 
in PBS (pH 7.2). After 
24 h, fixed tissues were changed to 70%
 
(v/v) ethanol and then embedded in Paraplast 
Plus (Oxford Labware).
 
The remainder of the uterine horn was frozen in liquid nitrogen
 
and stored at –80°C for RNA extraction.  
 
A  Gene Identification Procedures  
RT-PCR Analysis  
Expression of Irf1, Irf2, Irf6, Irf7, Isg15, Mx1, Nmi, Oas2, Plscr1, Rsad2, and 
Stat1 studied
 
by RT-PCR as described previously [62-65]. Primers
 
for each component 
were derived from mouse genes using Primer 3[64]. A partial murine
 
cDNA of 300–700 
bp was cloned by RT-PCR using total RNA
 
isolated from the uterus.  Primer and 
annealing temperatures used for PCR
 
are summarized in Table 1. The amplified PCR 
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products were subcloned
 
into the pCRII cloning vector using a T/A Cloning Kit 
(Invitrogen
 
Life Technologies) and sequenced in both directions using an
 
ABI PRISM 
Dye Terminator Cycle Sequencing Kit and ABI PRISM
 
automated DNA sequencer 
(Perkin-Elmer Applied Biosystems) to
 
confirm identity.
 
 
 
In Situ Hybridization  
In situ hybridization analysis of ovine uteri were conducted
 
using methods 
described previously [66]. Briefly, deparaffinized,
 
rehydrated, and deproteinated cross- 
 
 
 
Primer GenBank Accession No. Primer sequence 5’ – 3’ 
(forward and reverse ) 
Annealing temp. 
(C) 
Product size 
(bp) 
Irf1 NM_008390 CCAGCCGAGACACTAAGAGC 
CTTCGGCTATCTTCCCTTCC 
55.0˚ 330 
Irf2 NM_008391 CTCCGCTCTTCAGAAACTGG 
TGCGTTCTCTTCATCACTGG 
55.0˚ 584 
Irf6 NM_016851 TGTGGAGACCGGAAAGTACC 
ACCGTTGATGTTCAGGAAGG 
55.0˚ 328 
Irf7 NM_016850 CTTCTTGCTTCAGGTTCTGC 
TGCCTACTTCCCAGTATACC 
55.0˚ 470 
Isg15 NM_015783 CCGTGACTAACTCCATGACG 
CTGGTCTTCGTGACTTGTTC 
54.0˚ 302 
Mx1 NM_01084 CCGTATCAGAGGGAGACAGC 
TCTCCCAATATTCCGTCTGC 
54.5˚ 608 
Nmi AF019249 GAATCATGTCGTGCAGATGG 
TTGACCACCTCCACTTCTCC 
55.0˚ 516 
Oas2 NM_145227 ATGCCACTTTTCGTCACTCC 
CCTGAGGGTGAAGTCAGACC 
54.5˚ 483 
Plscr1 NM_011636 ACTGCTGTACCCGAAACTGC 
TCACAAAACCAGACCACTGC 
54.5˚ 353 
Rsad2 BC057868 AGATGGGAACAGCACTCAGC 
AGATTCAGGCACCAAACAGG 
55.0˚ 694 
Stat1 NM_009283 GAAGAGCGACCAAAAACAGG 
GAATGAGCTGCTGGAAGAGG 
54.5˚ 377 
TABLE 1.  Sequences for primers for RT-PCR 
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sections (5 µm) of
 
the uteri were hybridized with radiolabeled
 
sense or antisense cRNA 
probes generated from linearized plasmid
 
DNA templates using in vitro transcription 
with [
35
S- ]UTP. After
 
hybridization, washing, and ribonuclease A digestion, slides
 
were 
dipped in NTB-2 liquid photographic emulsion (Kodak), stored
 
at 4°C for 4 to 40 days, 
and developed in Kodak D-19
 
developer. Slides were then counterstained with Gill's 
modified
 
hematoxylin (Stat Lab), dehydrated through a graded series of
 
alcohol to 
xylene, and protected with a coverslip.
  
 
Photomicroscopy  
Relative amounts of mRNA expression from in situ hybridization were assessed 
visually in uterine sections from each mouse by two independent
 
observers and scored as 
present or absent (no signal stronger than sense).  If histologically
 
discernable, notations 
were made declaring location (LE, GE, S, D, etc.) of strongest and/or most variable 
change over gestational days.  Images of representative fields
 
of sections hybridized with 
antisense or sense cRNAs were recorded
 
under brightfield or darkfield illumination with 
a Nikon Eclipse
 
1000 photomicroscope (Nikon Instruments Inc.) fitted with a
 
Nikon 
DXM1200 digital camera using constant image acquisition
 
parameters to ensure accurate 
comparison.  
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IV       RESULTS 
A  Cell Type Identification 
One important requirement of this research is that not only should it detect up-
regulation of the specified gene, but also that the location (cell type) of the mRNA 
activity can be identified according to gestational day (GD).  Therefore, it is important to 
recognize major cell types on the histological sample.  Such cell types have been 
identified in Figure 1.  
 
 
 
 
 
 
 
 MY   
 
 
 
  
 
B   Signal Recognition 
 Experimental tissues subjected to in situ hybridization result in localized 
radioactive decay at the location of mRNA occurrence.  Although the site of radiation 
emission cannot be seen by brightfield microscopy, this radiation signal is preserved by 
FIG. 1. Cell types labeled in tissue cross section of GD 5 and 8. MS, mesometrium; LE, luminal epithelium;  S, 
stroma; GE, glandular epithelium; MY, myometrium; D, Decidua; E, Embryo. 
 MS  
 LE  
  S 
MY  
 GE 
GD5 
MY  
      E  
      D  
GD8 
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exposure to liquid radiographic film, which deposits silver grains on the tissue.  The 
presence of mRNA then can be detected in its original location by dark field 
microscopy.  The results here are coupled with bright field microscopy for orientation 
reference.  For example, see the schematic representative diagram in Figure 2.   
  
 
 
 
 
 
 
 
 
 
 
 
In situ hybridization studies with radiolabeled sense probe was used as negative 
control and was used for comparison of antisense expression. 
 
C  Summary of Results  
 The in situ hybridization studies that yielded a positive result are summarized in 
Figures 3, 4, and 5 under both bright field and dark field microscopy according to gene 
and gestational day.  Individual findings will be reported subsequently.   
FIG. 2. – A schematic representation of post-ISH tissue slide with 
localized radioactivity, as seen  a) in its  theoretical state,  b) under 
bright field microscopy, and  c) under dark field microscopy      
 
 
     Radioactive signal 
a)         
 
  Tissue 
                          
 
 
b) 
 
 
 
 
Preserved signal  
c)  
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FIG. 6  ISH analysis of Irf6 in endometria on GD3 of 
pregnancy in dark-field and bright-field illumination 
for each respective gene. LE, luminal epithelium; GE, 
glandular epithelium.  
 
 
 
 GD3            
D    Peri-implantation Signal  
In situ hybridization (ISH) studies found Ifr6 mRNA expression in uterine LE 
cells and GE cells.  During gestational days 2-5, the Irf6 signal is the most strong, which 
can be seen in Figures 3 and 6 under brightfield microscopy (BF) and darkfield 
microscopy (DF).   This finding in addition to the role it plays in tissue development and 
remodeling has made it of particular interest to further studies.  
 
  
 
 
 
 
 
 
Additionally, ISH studies indicate that Oas2 and Plscr1 mRNA are also 
expressed in the uterine LE.  Similarly, mRNA expression peaked during the peri- 
implantation period, namely GDs 1-5 and 2-4, respectively.  These findings can be seen 
in Figures 4, 5, 7, and 8.     
 
 
 
 
  
 
  
 
LE 
 
GE 
FIG. 7.   ISH analysis of Oas2 in endometria on GD4 
and GD5 of pregnancy in dark-field and bright-field 
illumination. LE, luminal epithelium.  
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E      Post-implantation Decidual Signal 
Many of the genes investigated (Tlr4, Isg15, Nmi, Oas2, Irf1, Irf2, Irf7) showed 
mRNA expression in the decidua that was the greatest on gestational days 7-9.  As 
previously discussed, decidualization is a process in which a significant change in 
cellular composition and morphology occurs in the endometrial tissue.  This process 
begins around the time of implantation immediately adjacent to the implantation site.  
Over the several days following this event, the decidualization reaction radiates to the 
entire breadth of the endometrium.   
Because of the location of the ISH signal produced for these genes, it is 
speculated that these genes may have a role in the decidualization process.  These results 
can be seen in Figure 9 under bright field microscopy (BF) and dark field microscopy 
(DF).  
   LE 
 
  
 GE 
LE 
 
GE 
   LE 
 
  
 GE 
LE 
 
GE 
 
  GD3            
  GD4            
FIG. 8.   ISH analysis of Plscr1in endometria on GD3 
and GD4 of pregnancy in dark-field and bright-field 
illumination. LE, luminal epithelium.  
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FIG. 9.  ISH analysis of decidual ISGs in 
endometria on GD7 and GD9 of pregnancy in 
dark-field and bright-field illumination. 
E,embryo; D, Decidua. 
23 
 
 
 
FIG. 10.    Tlr4  ISH analysis in endometria on GD11 of 
pregnancy in dark-field and bright-field illumination. F, 
fetal Tissue; U, Umbilical tissue.  
 
 
  GD11            
  GD11            
 
F      Other Notable Findings  
In addition to the decidual mRNA expression, Tlr4 produced interesting results 
in late gestation.  The investigatory gene mRNA was highly expressed in the umbilical 
cord, while absent in the fetus (see Figure 10). 
 
 
  
 
 
  
  
  
 
  
Similarly, Rsad2 was expressed in placental tissue.  This signal could be seen 
most intensely after GD 9 and was absent in the fetal tissue.  (See Figure 11.) 
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G       No Result 
Finally, Mx1 and Stat1 showed no result.  In the case of Mx1, RT-PCR yielded 
no product, and in situ hybridization studies were not attempted.  This was to be 
expected as it is known that highly inbred mice, such as those routinely used in 
laboratory studies, carry deletions and/or mutations in the Mx genes [67].   Stat1, 
however, had a successful RT-PCR study, however mRNA expression was below 
detectable limits in our ISH studies. 
  
 
FIG. 11.    ISH analysis of Rsad2 in endometria on GD11 of 
pregnancy in dark-field and bright-field illumination. F, fetal 
Tissue; P, placental tissue. 
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V       DISCUSSION 
 As discussed, several genes are specifically expressed around the time of 
implantation: Irf6, Oas2, and Plscr1.  In order for implantation to be successful, the 
conceptus must approach the uterine wall with a specific orientation, uterine tissue must 
undergo conformational modifications, the conceptus must hatch from the ZP, the 
microvilli between the conceptus and uterine epithelium must interdigitate, the lumen 
mist close around the conceptus, the conceptus must invade the uterine endometrium, 
and, finally, in tandem, the uterine endometrium must permit invasion by the conceptus 
[13]. 
 Although the mechanisms for many of these processes are unknown, it is clear 
that the entire process is continuous and depends on constant combative input from both 
the maternal and fetal signals.  It is interesting that the genes found to be expressed in 
this study around the time of implantation are those that are known to induce tissue 
remodeling, growth and development, and cell communication.   Now that these genes 
have been identified, further study is needed to investigate the specific gestational 
functions of these genes.  
 Accompanying implantation, decidualization occurs in the stromal tissue 
immediately surrounding the implantation site.  Over time, this reaction initiation 
radiates through the uterine stroma [14].  Interestingly, many of the genes studied that 
have positive ISH signals after gestational day 5, display a signal that encircles the 
conceptus from a distance (refer to Figure 9).  In addition, many of these genes are 
known to function as signal transducers, transcriptional modifiers, and proliferation and 
26 
 
 
 
differentiation regulators.  It is possible that the genes identified are active participants in 
decidualization.  As previously stated, these genes will also need further study to 
investigate these claims.  
 Finally, Tlr4 and Rsad2 may have a role in placental and umbilical development 
and maintenance.  This is likewise speculated based on the extent of mRNA expression 
of these genes in their respective histological locations.  As addressed, these functional 
speculations demand further study.    
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